Federal Supply Schedule 36F79724D0212
Award Date
9/29/24
Last Date to Order
9/28/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Leading Pharma LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Leading Pharma LLC, provides for the procurement of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The single-award, indefinite delivery/indefinite quantity (IDIQ) contract has a period of performance through January 31, 2025 and a ceiling value of $225,000.00.
The contract aims to meet the VA's requirements for a wide range of pharmaceuticals...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods.
The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded to Haleon US LP, a for-profit manufacturer, with a ceiling value of $9,867,650.00 and a period of performance through September 30, 2026.
The FSS contract, categorized under Schedule 65 IB, aims to provide the VA's VISN 12 with a wide...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028.
The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,980,000.00 and a period of performance that runs through January 1, 2026.
The contracted products and services under this multiple award FSS-61-IB schedule include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Llorens Pharmaceutical International...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028.
The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB.
The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Provepharm Inc., a foreign-owned, self-certified small disadvantaged business organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B.
The contract has a ceiling value of $25,000.00 and a performance period ending on March 15, 2023. It was awarded on October 10, 2022 and is not set...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Legacy Pharma USA, Inc. The multiple-award contract has a ceiling value of $25,000.00 and a period of performance through September 15, 2023.
The contract provides for the interim delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. As a Federal Supply...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, aims to procure a variety of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,163,260.00 and a period of performance that extends through April 14, 2028.
The prime contractor for this multiple-award FSS contract is Spectrum Pharmaceuticals, Inc., a for-profit organization and manufacturer of goods. The...